Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 856867-55-5 Chemical Structure| 856867-55-5

Structure of Tedizolid phosphate
CAS No.: 856867-55-5

Chemical Structure| 856867-55-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tedizolid Phosphate is an oxazolidinone-class antibiotic prodrug used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of several Gram-positive bacteria.

Synonyms: TR-701FA; Tedizolid(phosphate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tedizolid phosphate

CAS No. :856867-55-5
Formula : C17H16FN6O6P
M.W : 450.32
SMILES Code : O=C1O[C@@H](COP(O)(O)=O)CN1C2=CC=C(C3=CC=C(C4=NN(C)N=N4)N=C3)C(F)=C2
Synonyms :
TR-701FA; Tedizolid(phosphate)
MDL No. :MFCD28098176
InChI Key :QCGUSIANLFXSGE-GFCCVEGCSA-N
Pubchem ID :11476460

Safety of Tedizolid phosphate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MRSE IDRL-8883 2 µg/ml Determine the MBIC of Tedizolid against MRSE biofilm PMC5278734
Enterococcus faecium TX82 0.5 μg/ml Determine the MIC of Tedizolid against E. faecium TX82 PMC6437489
MRSE IDRL-8883 ≥32 µg/ml Determine the MBBC of Tedizolid against MRSE biofilm PMC5278734
MRSE IDRL-8883 0.5 µg/ml Determine the MIC of Tedizolid against MRSE PMC5278734
Staphylococcus aureus MRSA CM-05 cfr+ 0.5 μg/ml Determine the MIC of Tedizolid against MRSA CM-05 cfr+ PMC6437489
Enterococcus faecalis OG1RF 0.5-1 μg/ml Determine the MIC of Tedizolid against E. faecalis OG1RF PMC6437489
Mycobacterium tuberculosis 0.015-16 μg/ml Tested the in vitro activity of Tedizolid against 120 strains of Mycobacterium tuberculosis (including susceptible, first-line-resistant, and multidrug-resistant isolates), with MIC90 and MIC50 of 0.5 and 0.25 μg/ml, respectively PMC6437524
Staphylococcus aureus MRSA CM-05 cfr-cured 0.5-1 μg/ml Determine the MIC of Tedizolid against MRSA CM-05 cfr-cured PMC6437489
Enterococcus faecium TX4320 cfr(B) 2 μg/ml Determine the MIC of Tedizolid against E. faecium TX4320 cfr(B) PMC6437489

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats MRSE foreign body-associated osteomyelitis model Intraperitoneal injection 30 mg/kg Once daily for 14 days Evaluate the efficacy of Tedizolid alone or in combination with rifampin in treating MRSE foreign body-associated osteomyelitis. Results showed that Tedizolid monotherapy significantly reduced bacterial counts, and the combination of Tedizolid with rifampin was as effective as vancomycin plus rifampin. PMC5278734
ICR mice Mouse peritonitis model Oral 10 mg/kg Every 24 hours Evaluate the in vivo efficacy of Tedizolid against E. faecium TX82, E. faecium TX4320 cfr(B), E. faecalis OG1RF, and MRSA CM-05 cfr+. Results showed significant protection by Tedizolid against E. faecium TX82, E. faecalis OG1RF, and MRSA CM-05 cfr+, but less efficacy against E. faecium TX4320 cfr(B). PMC6437489
Rat Experimental endocarditis model Intravenous injection 70 mg/kg Every 24 hours for 5 days To evaluate the efficacy of Tedizolid as monotherapy for endocarditis, results showed that Tedizolid as monotherapy was ineffective against all 3 strains tested PMC7179605
New Zealand White rabbits MRSA necrotizing pneumonia model Intravenous injection 6 mg/kg Twice daily for 48 hours To evaluate the protective efficacy of tedizolid phosphate in the MRSA necrotizing pneumonia model and its suppression of staphylococcal toxin production. Results showed that the overall survival rate was 83% for rabbits treated with tedizolid phosphate, significantly higher than those treated with vancomycin (17%) or saline (17%). Additionally, tedizolid phosphate significantly inhibited the production of alpha-toxin and PVL in the lungs. PMC5365717

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02342418 Obesity PHASE4 COMPLETED 2025-12-15 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.10mL

2.22mL

1.11mL

22.21mL

4.44mL

2.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories